RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 Profiling Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Targetable Genetic Alterations
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 12
IS 20
SP 8
OP 8
DO 10.1177/155989771220003
UL http://mdc.sagepub.com/content/12/20/8.abstract
AB Neoadjuvant chemotherapy (NACT) is now widely used in the management of locally advanced breast cancer and in patients with relatively large tumors who are interested in breast conservation. Patients who do not have a complete pathologic complete response typically have poorer outcomes compared with patients with a pCR [Rastogi P et al. J Clin Oncol 2008]. This article presents molecular profiling data on residual triple-negative breast cancer after NACT.